Hideshima T, Mitsiades C, Akiyama M, et al. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor ps-341. Blood.2003; 101: 1530-1534.
日本骨髄腫研究会編. 多発性骨髄腫の診療指針第2版. 文光堂: 2008.
Knudsen LM, Hjorth M, Hippe E for the Nordic Myeloma Study Group. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Eur J Haematol.2000: 65 175-181.
Blade J, Fernández-Llama P, Bosch F, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med.1998: 158: 1889-1893.